Marijuana Business Magazine - May-June 2018

does not know the game. We don’t have the people on staff and the expertise at Salk to get drugs into clinical trials,” said Schubert, noting that he has three drug can- didates he believes are ready to enter clinical trials. “This was a good opportunity to get somebody interested in what we’re doing, if we are able to move things forward.” Drug Development Vet Joins Cannabinoid Company Vancouver-based InMed Pharmaceuticals, a biopharma- ceutical company specializing in the research and develop- ment of cannabinoid-based drug therapies, appointed Eric Hsu as vice president of preclinical research and develop- ment, giving him primary responsibility for advancing the firm’s cannabinoid biosynthesis-manufacturing process and preclinical research on new drug candidates including INM- 085 for glaucoma and INM-405 for pain. Before joining InMed, Dr. Hsu held various positions with enGene, including vice president of research and vice president of scientific affairs and operations. He has cowritten more than 25 publications and abstracts and holds five patents. Investment-Operations Company Enlists ER Doc Toronto-based Liberty Health Sciences, a company that invests in and operates cannabis companies in the United States and Canada, hired Dr. Jennifer Timothee Oliveras as its medical director. Timothee has been a practicing emergency physician in Florida since 2013. Washington DC Dispensary Hires CFO Takoma Wellness Center, a Wash- ington DC dispensary, hired Don Grede as chief financial officer. Grede has been in the marijuana industry since 2012. He co-founded Aquarius Cannabis, a marijuana-focused branding and distribution com- pany, and most recently was CEO of Superior Leaf, the Don Grede Jennifer Timothee Oliveras May-June 2018 • Marijuana Business Magazine • 137